Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy:in vivoassessment of structural changes

Abstract

Adrenomyeloneuropathy is the late-onset form of X-linked adrenoleukodystrophy, and is considered the most frequent metabolic hereditary spastic paraplegia. In adrenomyeloneuropathy the spinal cord is the main site of pathology. Differently from quantitative magnetic resonance imaging of the brain, little is known about the feasibility and utility of advanced neuroimaging in quantifying the spinal cord abnormalities in hereditary diseases. Moreover, little is known about the subtle pathological changes that can characterize the brain of adrenomyeloneuropathy subjects in the early stages of the disease. We performed a cross-sectional study on 13 patients with adrenomyeloneuropathy and 12 age-matched healthy control subjects who underwent quantitative magnetic resonance imaging to assess the structural changes of the upper spinal cord and brain. Total cord areas from C2-3 to T2-3 level were measured, and diffusion tensor imaging metrics, i.e. fractional anisotropy, mean, axial and radial diffusivity values were calculated in both grey and white matter of spinal cord. In the brain, grey matter regions were parcellated with Freesurfer and average volume and thickness, and mean diffusivity and fractional anisotropy from co-registered diffusion maps were calculated in each region. Brain white matter diffusion tensor imaging metrics were assessed using whole-brain tract-based spatial statistics, and tractography-based analysis on corticospinal tracts. Correlations among clinical, structural and diffusion tensor imaging measures were calculated. In patients total cord area was reduced by 26.3% to 40.2% at all tested levels (P < 0.0001). A mean 16% reduction of spinal cord white matter fractional anisotropy (P ≤ 0.0003) with a concomitant 9.7% axial diffusivity reduction (P < 0.009) and 34.5% radial diffusivity increase (P < 0.009) was observed, suggesting co-presence of axonal degeneration and demyelination. Brain tract-based spatial statistics showed a marked reduction of fractional anisotropy, increase of radial diffusivity (P < 0.001) and no axial diffusivity changes in several white matter tracts, including corticospinal tracts and optic radiations, indicating predominant demyelination. Tractography-based analysis confirmed the results within corticospinal tracts. No significant cortical volume and thickness reduction or grey matter diffusion tensor imaging values alterations were observed in patients. A correlation between radial diffusivity and disease duration along the corticospinal tracts (r = 0.806, P < 0.01) was found. In conclusion, in adrenomyeloneuropathy patients quantitative magnetic resonance imaging-derived measures identify and quantify structural changes in the upper spinal cord and brain which agree with the expected histopathology, and suggest that the disease could be primarily caused by a demyelination rather than a primitive axonal damage. The results of this study may also encourage the employment of quantitative magnetic resonance imaging in other hereditary diseases with spinal cord involvement.

Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy

“…In this cross-sectional study, we show that the myelopathy of ALD is associated with thinning of the retinal nerve fiber layer on OCT. While axonal degeneration with thinning of the spinal cord has been demonstrated in ALD patients compared to controls [6], our results show that this axonal degeneration is also measurable in the retina. Moreover, the retinal neurodegeneration correlates with clinical outcome measures of myelopathy.…”

“…ALD is a genetic neurometabolic disorder caused by a defect in the degradation of very long-chain fatty acids (VLCFA), leading to their accumulation in various tissues [3,4]. Virtually all men with ALD develop myelopathy, characterized neuropathologically by degeneration of the corticospinal tracts, spinothalamic tracts and dorsal columns of the spinal cord [5,6]. Clinically, it presents as a slowly progressive gait disorder due to a spastic paraparesis and sensory ataxia [7].…”

Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients

“…While many MR imaging techniques have been used to investigate ALS biomarkers and disease progression [33,37], the primary focus has been the CNS tissue, rather than the CSF surrounding that tissue. Conversely, research evaluating ALS molecular biomarkers in the CSF has been well established for many decades with a large number of possible disease biomarkers identified often in elevated levels.…”

Sensorimotor and pain‐related alterations of the gray matter and white matter in Type 2 diabetic patients with peripheral neuropathy

“…DTI data were processed using FSL (Castellano et al, ; Guimaraes et al, ). The DTI scans for each participant were first corrected for head motion and eddy currents using affine registration and then brain‐extracted using the Brain Extraction Tool.…”